About UsMembershipMarketplaceResourcesGlobal Business Atlas
Top AI CompaniesTop Blockchain Influencers & AuthorsTop Global Digital AgenciesBusinessabc Country IndexesTop Accelerators and Chambers of CommerceTop Public Companies by MarketcapBusinessabc Education IndexesTop Malaysian Companies
DirectoryCompaniesLeadersInvestorsUniversitiesOrganisations
Loading wiki page…

Get Your Own Businessabc AI Visibility ID

Boost AI visibility, credibility, and discoverability

Learn More
Last Updated: 2026
Dechra Pharmaceuticals image

Dechra Pharmaceuticals

Rank#2371
Market Cap5.44B
CountryUnited Kingdom
Summary
History
Mission
Vision
References
Summaryarrow
Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.
Historyarrow

The Company was founded in 1997 by way of a management buy-out from Lloyds Chemists. It was first listed on the London Stock Exchange in 2000. In 2007 it bought VetXX, a Danish veterinary products business, for £62 million. In 2010 it purchased Florida-based DermaPet for US$64 million and Sussex-based Genitrix for £5 million.It sold its veterinary services business to US-firm, Patterson Companies, for £87.5m in July 2013 in order to focus on its higher margin manufacturing business.

Missionarrow
Dechra Pharmaceuticals PLC is committed to providing quality animal health products and services to our customers and the development of innovative solutions in animal health.
Visionarrow
To be the first-choice partner and supplier of innovative, reliable and quality animal health products and services with the highest ethical standards.
Referencesarrow

https://en.wikipedia.org/wiki/Dechra_Pharmaceuticals

https://in.investing.com/equities/dechra-pharma

https://finance.yahoo.com/quote/DPH.L/profile?p=DPH.L

https://www.crunchbase.com/organization/dechra-pharmaceuticals

https://companiesmarketcap.com/

https://www.dechra.com

Share

Leadership team
M
Mr. Ian D. Page (CEO, MD & Exec. Director)
M
Mr. Paul Nicholas Sandland MAAT, FCCA (CFO & Exec. Director)
D
Dr. Anthony Gerard Griffin (MD of Dechra Veterinary Products for Europe & Exec. Director)
Products / Services
Biotechnology, Pharmaceutical, Veterinary
Number of Employees
1,000 - 20,000
Address
Cheshire, Connecticut, United States
Established
1997-01-01
Net Income
S_20M_100M
Revenue
500M - 1B
Traded as
DPH.L
Website
https://www.dechra.com
Social Media
linkedinfacebookx
Last Updated: 2026
Logo

Businessabc provides digital business directory, digital blockchain AI certification, resources, and marketplace for businesses, organisations, and professionals.

Contacts

Email
Contact

Follow Us

Created Produced

Partner logo
Partner logo

Tech AI Media Platforms

Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo

Copyright 2026 © Businessabc powered by

Powered by ztudium group

DisclaimerPrivacy PolicyTerms of Service
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo